SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE

The medical condition or reason for a Sexual Health and HIV Episode.

National Codes

Code Description
A1 Primary syphilis
A2 Secondary syphilis
A3 Early latent syphilis
A4 Cardiovascular syphilis
A5 Neurosyphilis
A6 All other late and latent syphilis
A7A Congenital syphilis
A10 Ocular syphilis
A11 Otosyphilis
B Gonorrhoea
C1 Chancroid
C2 Lymphogranuloma venereum (LGV)
C3 Donovanosis
C4 Chlamydial infection
C4N Non-specific genital infection (NSGI)
C5A Pelvic inflammatory disease (PID) and epididymitis
C5B Ophthalmia neonatorum
C6A Trichomoniasis
C6B Anaerobic/Bacterial vaginosis and anaerobic balanitis
C6C Other vaginosis/vaginitis/balanitis
C7A Anogenital candidosis
C8 Scabies
C9 Pediculosis pubis
C10A Anogenital Herpes simplex: First episode
C10B Anogenital Herpes simplex: Recurrent episode
C11A Anogenital warts infection: First episode
C11D Anogenital warts infection: Recurrent episode
C12 Molluscum contagiosum
C13 Viral hepatitis B (HbsAg positive): First diagnosis
C14 Viral hepatitis C: First diagnosis
C15 Viral hepatitis A: Acute infection
C16 Mycoplasma genitalium
D2A Urinary Tract Infection
D2B

Other conditions requiring treatment at Level 3 Genitourinary Medicine Services

H HIV positive - Previously Diagnosed
H1 New HIV diagnosis
H1A New HIV diagnosis: Acute
H1B New HIV diagnosis: Late infection (AIDS defined)
H2 Attendance for HIV-related care
P4A Cervical cytology: minor abnormality
P4B Cervical cytology: major abnormality
T1 Chlamydia test
T2 Chlamydia and gonorrhoea tests
T3 Chlamydia, gonorrhoea and syphilis tests
T4 Chlamydia, gonnorrhoea, syphilis and HIV antibody tests
T5 Herpes Simplex Virus (HSV) Test
T6 Hepatitis A/B/C Test
TS Microscopy
TT 3 Site Testing (chlamydia and gonorrhoea)
T7 Syphilis and HIV Testing
T8 Self sampling (urinalysis/swabs) without Health Care worker (HCW) consultation
T9 STI testing not required/appropriate
T10 Rapid testing (STI and/or HIV)
T11 Chlamydia test declined
T12 Mycoplasma genitalium test
O20 Hepatitis A vaccination: 1st dose
O21 Hepatitis A vaccination: Subsequent dose
O22 Hepatitis A immune
O23 Partner notification related attendance: Hepatitis A contact
O31 PrEP eligibility criteria 1: MSM/transgender woman
O32 PrEP eligibility criteria 2: HIV positive partner
O33 PrEP eligibility criteria 3: Other high risk
O41 PrEP regimen: Starting or continuing daily Prep
O42 PrEP regimen: Starting or continuing event based Prep
O43 PrEP regimen: Continued through other source
O44 PrEP regimen: Offered and declined
O45 PrEP regimen: Stopped
O51 PrEP prescription: 30 tablets
O52 PrEP prescription: 60 tablets
O53 PrEP prescription: 90 tablets
O60 PrEP patient characteristic: Transgender
P1A Human Immunodeficiency Virus (HIV) antibody test (no sexual health screen)
P1B Human Immunodeficiency Virus (HIV) antibody test offered and refused
P1C HIV test inappropriate
P2A Hepatitis B vaccination: 1st dose
P2B Hepatitis B vaccination: 2nd dose
P2C Hepatitis B vaccination: 3rd dose
P2D Hepatitis B vaccination: 4th dose
P2E Hepatitis B vaccination: Booster
P2I Hepatitis B immune
P3 CONTRACEPTION

and family planning advice (excluding condom provision)

P4 Cervical cytology done
REF1

Referral from Chlamydia Screening Programme

REF2

Referral to a Level 3 Genitourinary Medicine Service

REF3 Referral from home testing/sampling service
SG1 Shigella flexneri (group B)
SG2 Shigella sonnei (group D)
SG3 Shigella other/unspecified
SRH

Sexual and Reproductive Health PATIENT

W1 HPV vaccination: 1st dose
W2 HPV vaccination: 2nd dose
W3 HPV vaccination: 3rd dose
W4 HPV vaccination: offered and declined
W5 HPV vaccination: previously received in full
PN Partner notification initiated related attendance
PNC Partner notification related attendance: Chlamydia contact
PNG Partner notification related attendance: Gonorrhoea contact
PNH Partner notification related attendance: HIV contact
PNN Partner notification related attendance: Non-specific genital infection contact
PNP Partner notification related attendance: PID/Epididymitis contact
PNS Partner notification related attendance: Syphilis contact
PNT Partner notification related attendance: Trichomoniasis contact
PR1 Pregnant 1-12 weeks
PR2 Pregnant 13-28 weeks
PR3 Pregnant 29-40 weeks
PEPS Post exposure prophylaxis after sexual exposure (PEPSE)
D3

Other Sexual Health and HIV Episodes  not requiring treatment

O11-O99 Research/New/Urgent reporting (Retired 01 October 2018)
40 Sexual Assault (Acute presentation)
41 Sexual Assault (Non - acute presentation)
CSE1 Child sexual exploitation : concerns raised at internal assessment
CSE2 Child sexual exploitation : concerns raised with internal safeguarding professionals
CSE3 Child sexual exploitation : referred to external safeguarding professionals
DV Concern of domestic violence (or abuse)
FGM Female genital mutilation (of any type)
Z Prisoner
SW Sex Worker
R Rectal infection
O Pharyngeal infection
X Previously diagnosed elsewhere
M Medication given
Q Quadrivalent HPV vaccine
A1X Primary syphilis - previously diagnosed elsewhere
A2X Secondary syphilis - previously diagnosed elsewhere
A3X Early latent syphilis - previously diagnosed elsewhere
A4X Cardiovascular syphilis - previously diagnosed elsewhere
A5X Neurosyphillis syphilis - previously diagnosed elsewhere
A6X All other late and latent syphilis - previously diagnosed elsewhere
A7AX Congenital syphilis - previously diagnosed elsewhere
BR Gonorrhoea - rectal infection
BO Gonorrhoea - pharayngeal infection
BX Gonorrhoea - previously diagnosed elsewhere
BM Gonorrhoea - medication given
BRX Gonorrhoea - rectal infection, previously diagnosed elsewhere
BRM Gonorrhoea - rectal infection, medication given
BOX Gonorrhoea - pharayngeal infection, previously diagnosed elsewhere
BOM Gonorrhoea - pharayngeal infection, medication given
C4R Chlamydia - rectal infection
C4O Chlamydia - pharayngeal infection
C4X Chlamydia - previously diagnosed elsewhere
C4M Chlamydia - medication given
C4RX Chlamydia - rectal infection, previously diagnosed elsewhere
C4RM Chlamydia - rectal infection, medication given
C4OX Chlamydia - rectal infection, previously diagnosed elsewhere
C4OM Chlamydia - pharayngeal infection, medication given
C2R Lymphogranuloma venereum (LGV) - Rectal infection
C2O Lymphogranuloma venereum (LGV) - Pharayngeal infection
C4NR Non-specific genital infection (NSGI) - rectal infection (proctitis)
C6AX Trichomoniasis - previously diagnosed elsewhere
H1X New HIV diagnosis - previously diagnosed elsewhere
H1AX New HIV diagnosis: acute - previously diagnosed elsewhere
H1BX New HIV diagnosis: late (AIDS defined) - previously diagnosed elsewhere
C10AM Anogenital Herpes simplex: first episode - medication given
C10BM Anogenital Herpes simplex: recurrent episode - medication given
C11AM Anogenital warts infection: first episode - medication given
C11DM Anogenital warts infection: recurrent episode - medication given
W1Q HPV Vaccination: 1st dose - quadrivalent vaccine
W2Q HPV Vaccination: 2nd dose - quadrivalent vaccine
W3Q HPV Vaccination: 3rd dose - quadrivalent vaccine

Also Known As

This attribute is also known by these names:

Context Alias
Formerly GENITOURINARY EPISODE TYPE
Plural SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPES

Where Used

Type Link How used
Class ACTIVITY PROPERTY has an attribute SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE of type SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE
Data Element SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE is the data element of SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE
Attribute ACTIVITY PROPERTY TYPE references in description SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE
Attribute PRISONER INDICATOR references in description SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE
Attribute SEX WORKER INDICATOR references in description SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE
Data Element SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE references in description SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE